Introduction

Fever and infection are among the most common reasons children are brought for medical evaluation. Deciding whether an illness is caused by bacteria, which may need antibiotics, or by a virus, which usually does not, can be difficult using symptoms alone. The Rapid Procalcitonin (PCT) Test Kit was developed to help address this challenge.

Procalcitonin (PCT) is a protein that the body produces in larger amounts when there is a bacterial infection, especially a severe one such as sepsis. Measuring its level in blood can support clinical judgment, particularly in emergency and intensive care settings.

This test is generally considered to have a favorable safety profile. It does not involve radiation, and the sample collection method, whether a finger prick or a small blood draw, is a routine and minimally invasive procedure already familiar in pediatric care.

History of the Device

Procalcitonin was first identified as a potential marker of bacterial infection in the early 1990s, when researchers observed that its blood levels rose sharply in patients with severe bacterial infections and sepsis, while remaining relatively low in viral illness or non-infectious inflammation.

The first laboratory-based procalcitonin assays became commercially available in the mid-1990s, initially used mainly in hospital laboratories for critically ill adults. Over the following decade, the assay technology was refined for greater sensitivity and turnaround speed.

As demand grew for faster results at the bedside, manufacturers developed point-of-care rapid test formats, allowing PCT measurement outside of central laboratories. These rapid formats were later adapted and validated for use in pediatric and neonatal populations, where earlier detection of serious bacterial infection can meaningfully affect outcomes.

Today, procalcitonin testing exists in both quantitative laboratory formats and rapid, semi-quantitative point-of-care formats. It is used worldwide across emergency departments, neonatal units, and general pediatric wards, with ongoing research continuing to refine its role in guiding antibiotic use.

Purpose of the Device and Where It Is Used

The Rapid PCT Test Kit measures the concentration of procalcitonin in a blood sample. A rising or elevated level may suggest a bacterial infection, and in some cases, the severity of illness such as sepsis. It is often used alongside clinical examination and other laboratory tests, not as a stand-alone diagnostic tool.

Common use cases include:

• Assessing children with fever without an obvious source
• Supporting decisions about starting or stopping antibiotic treatment
• Monitoring children being treated for suspected sepsis or serious bacterial infection
• Assisting in the evaluation of newborns with suspected early-onset infection
• Tracking response to treatment over the course of an illness

These devices are typically found in hospital emergency departments, neonatal intensive care units, pediatric wards, and some outpatient clinics. Larger laboratory-based systems are also used in central hospital laboratories.

Different Types of the Device

Laboratory Quantitative Immunoassay

This format is used in central hospital laboratories and provides a precise numerical procalcitonin value, usually reported in nanograms per milliliter (ng/mL). It generally requires specialized laboratory equipment and trained laboratory staff.

Point-of-Care Rapid Test (Lateral Flow / Semi-Quantitative)

This format is designed for use near the patient, such as in an emergency department or ward. It typically gives a result within 15 to 30 minutes and may show a semi-quantitative range rather than one exact number, though newer devices can offer more precise readings.

Automated Bedside Analyzer System

Some newer systems combine a small cartridge-based test with a compact automated reader, offering a more precise quantitative value at the point of care, closer in accuracy to laboratory testing.

Type	Typical Setting	Result Format	Approximate Turnaround Time
Laboratory Quantitative Immunoassay	Central hospital laboratory	Precise numerical value	1 to several hours
Point-of-Care Rapid Test	Emergency department, ward	Semi-quantitative range	15 to 30 minutes
Automated Bedside Analyzer	ICU, emergency department	Quantitative value	15 to 20 minutes

Parts and Components of the Device

Test Cartridge or Strip

Contains the chemical reagents and antibodies that react with procalcitonin in the blood sample to produce a visible or machine-readable signal.

Sample Collection Materials

Includes a lancet for finger-prick sampling or a needle and tube for venous blood draw, along with a capillary tube or dropper to transfer the sample onto the cartridge.

Reader or Analyzer Device

A compact instrument that reads the reaction on the cartridge and displays or prints the result. Some very basic kits are read visually without an analyzer.

Buffer Solution

A liquid included in the kit that helps the blood sample flow properly across the test strip and supports an accurate chemical reaction.

Control Strips or Cartridges

Used periodically to confirm that the reader and reagents are working correctly, helping maintain the reliability of results.

Component	Function	Typical Replacement Interval
Test Cartridge/Strip	Reacts with sample to detect PCT	Single use, per test
Lancet	Obtains finger-prick blood sample	Single use, per test
Buffer Solution	Aids sample flow and reaction	Per manufacturer expiry date
Reader/Analyzer	Reads and displays result	Serviced periodically per manufacturer schedule
Control Cartridge	Confirms device accuracy	Used per quality control schedule

How the Device Works

When a bacterial infection occurs, the body's cells release higher amounts of procalcitonin into the bloodstream, more so than during a viral infection. The test kit uses antibodies that specifically bind to procalcitonin present in a blood sample.

When the sample is applied to the test cartridge, the antibodies attach to any procalcitonin present and produce a colored line, glow, or electronic signal. The intensity or pattern of this signal corresponds to how much procalcitonin is in the sample. The reader device measures this signal and displays a result, either as a range or a specific number.

Step-by-Step User Guide

1. Prepare the equipment: Gather the test cartridge, lancet or blood collection tube, buffer solution, and reader device before starting.
2. Clean the collection site: Wipe the finger or the venous access site with an antiseptic swab and allow it to dry.
3. Collect the sample: Obtain a small blood sample using a lancet for a finger prick or through a standard venous draw, depending on the kit and clinical protocol.
4. Apply the sample: Place the required number of drops of blood onto the sample well of the test cartridge, following the manufacturer's marked volume.
5. Add buffer solution: Apply the buffer solution as instructed to help the sample flow across the reactive area of the strip.
6. Insert into the reader: Place the cartridge into the analyzer, if the kit uses one, and start the reading cycle.
7. Wait for the result: Allow the device to complete its reading cycle, typically within 15 to 30 minutes, without disturbing the cartridge.
8. Record and interpret the result: Note the displayed or visible result and interpret it alongside the child's clinical condition, following institutional protocol.

Precautions and Possible Dangers

• The test should not be used as the sole basis for diagnosing or ruling out a bacterial infection
• Improper sample collection or handling may lead to inaccurate results
• Hemolysis (damage to blood cells) or an inadequate sample volume may affect test accuracy
• Expired cartridges or improperly stored reagents may give unreliable readings
• The test does not detect the specific type or location of infection
• Certain non-infectious conditions may occasionally raise procalcitonin levels as well

How to Keep the Device Safe and Well Maintained

• Store test cartridges and buffer solutions at the temperature range specified by the manufacturer
• Check expiry dates on cartridges and reagents before each use
• Run control tests at recommended intervals to confirm the reader is functioning correctly
• Keep the reader device clean and free of dust, following the manufacturer's cleaning instructions
• Schedule periodic calibration or servicing of the analyzer as recommended by the manufacturer
• Keep software or firmware on digital analyzers updated when updates are provided
• Maintain a backup supply of cartridges and lancets to avoid interruptions in testing
• Store patient result data securely, following institutional data management policies

Interactive Tool: PCT Test Readiness Checklist

Interactive FAQ

Other Methods and Alternatives

Method	Basic Principle	Common Use
Rapid Procalcitonin (PCT) Test	Measures procalcitonin, a marker that rises with bacterial infection	Assessing bacterial infection or sepsis risk
C-Reactive Protein (CRP) Test	Measures a general inflammation marker	Screening for infection or inflammation, less specific for bacterial cause
Complete Blood Count (White Blood Cell Count)	Counts white blood cells that respond to infection	General infection screening
Blood Culture	Grows bacteria from a blood sample in a laboratory	Confirming presence and type of bacteria in the bloodstream
Erythrocyte Sedimentation Rate (ESR)	Measures how quickly red blood cells settle, reflecting inflammation	General, non-specific inflammation marker

Frequently Overlooked Points Worth Knowing

• Procalcitonin levels can vary with age, especially in the first days of life, so reference ranges differ for newborns
• A single result gives limited information; tracking the trend over repeated tests often provides more useful clinical insight
• Timing of the test relative to the onset of infection can affect the result, since procalcitonin levels change over the course of an illness
• Some non-infectious conditions, such as major trauma or certain treatments, may also raise procalcitonin levels temporarily
• A rapid point-of-care result and a laboratory result for the same sample may not always match exactly, due to differences in test technology

How to Read and Understand the Results

Result Parameter	What It Means
Low Procalcitonin Level	Bacterial infection is less likely, though it does not completely rule it out, especially very early in illness
Moderately Elevated Level	May suggest a localized or early bacterial infection; often interpreted alongside clinical findings
Highly Elevated Level	May suggest a more severe bacterial infection or systemic response such as sepsis
Rising Trend on Repeat Testing	May indicate progression of infection or inadequate response to treatment
Falling Trend on Repeat Testing	May suggest improvement or response to treatment

Age Group	Approximate General Reference Range
Newborns (first 48 hours)	May be naturally higher than in older infants
Infants and Older Children	Typically low in the absence of infection

Advantages and Limitations

Advantages

• May help distinguish bacterial infection from other causes of fever or illness
• Rapid point-of-care versions provide results faster than traditional laboratory culture methods
• Non-invasive beyond a standard blood sample, with no radiation exposure
• Can support decisions about starting, continuing, or stopping antibiotic treatment
• May be repeated to track a child's response to treatment over time

Limitations

• Cannot identify the specific organism or exact location of infection
• Results may be less reliable if the sample is collected very early in the illness
• Some non-infectious conditions can also raise procalcitonin levels
• Point-of-care versions may be somewhat less precise than full laboratory assays
• Requires proper storage, handling, and trained operation to remain reliable

Troubleshooting Common Problems

Problem	Possible Cause	Suggested Solution
No result displayed	Insufficient sample volume or expired cartridge	Repeat test with a fresh cartridge and adequate sample volume
Error message on reader	Cartridge inserted incorrectly or device malfunction	Reinsert cartridge correctly; if error persists, contact manufacturer support
Inconsistent results between repeat tests	Variation in sample quality or timing of illness	Follow standardized collection technique and note timing relative to symptom onset
Result does not match clinical picture	Test used as sole diagnostic basis, or sample handling error	Reassess sample handling; correlate result with full clinical evaluation
Reader fails to power on	Battery depletion or technical fault	Charge or replace battery; contact service provider if issue continues

When to Contact the Manufacturer or Service Provider

• The reader consistently fails to produce a result despite correct technique
• Control test results fall outside the expected range
• The device displays persistent error codes not resolved by basic troubleshooting
• Physical damage is noticed on the reader or accessories
• Software or firmware updates are needed for a digital analyzer

Suggested Reading and Official Resources

Readers who want more detailed or clinical information may refer to the following types of resources:

• Pediatric infectious disease textbook chapters covering biomarkers of bacterial infection and sepsis
• Peer-reviewed journal articles on procalcitonin-guided antibiotic therapy in children
• World Health Organization (WHO) resources on neonatal and pediatric sepsis management
• Manufacturer instructions for use and technical manuals for specific PCT test kits
• Guidelines published by pediatric infectious disease or critical care specialty societies